Hiroshi Sonoo
Okayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy.
Journal: Cancer letters
Published: June 25, 2014
Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Journal: Breast cancer (Tokyo, Japan)
Published: April 10, 2013
Specialists in endocrine and thyroid surgery
Journal: Nihon Geka Gakkai zasshi
Published: January 22, 2013
A pilot study of the reduced effects of adverse events caused by oral morphine and oxycodone after rotating to fentanyl patch in patients with metastatic breast cancer
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: April 17, 2012
Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone.
Journal: Breast cancer (Tokyo, Japan)
Published: April 06, 2012
Antitumor and anticancer stem cell activity of a poly ADP-ribose polymerase inhibitor olaparib in breast cancer cells.
Journal: Breast cancer (Tokyo, Japan)
Published: December 13, 2011
Long-term outcome of hypofractionated radiotherapy to the whole breast of Japanese women after breast-conserving surgery.
Journal: Breast cancer (Tokyo, Japan)
Published: November 29, 2011
The cell cycle profile test is a prognostic indicator for breast cancer patients treated with postoperative 5-fluorouracil-based chemotherapy.
Journal: Japanese journal of clinical oncology
Published: April 30, 2011
Clinicopathological significance of Y416Src and Y527Src expression in breast cancer.
Journal: Journal of clinical pathology
Published: April 15, 2011
Current trends in TSH suppression therapy for patients with papillary thyroid carcinoma in Japan: results of a questionnaire distributed to councilors of the Japanese Society of Thyroid Surgery.
Journal: Surgery today
Published: January 20, 2011
[A case of HER2 overexpressing advanced breast cancer with CTF therapy [cyclophosphamide, pirarubicin (THPADM), fluorouracil] showed long-term effectiveness after paclitaxel shock].
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: December 17, 2010
Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma.
Journal: ISRN endocrinology
Published: December 17, 2010
Last Updated: 09/26/2026